Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Astellas, Gilead Lose Bid to Block Pfizer Unit’s Lexiscan Copy

Sept. 22, 2022, 11:35 PM

Astellas Pharma Inc. and Gilead Sciences Inc. got temporary relief from a Pfizer Inc. unit’s launch of its Lexiscan copy, but a Delaware federal judge denied their request to block Hospira’s generic version while their appeal of a May noninfringement ruling continues.

Judge Colm F. Connolly, in an injunction order issued Thursday in the US District Court for the District of Delaware, temporarily barred Hospira from launching its generic, giving Astellas and Gilead until Oct. 5 to ask the Federal Circuit for an injunction pending resolution of the appeal.

  • Connolly found “that grounds do not exist to grant the ...